Publications by authors named "Damon Jack"

Claim this Profile
I
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
Claus Vogelmeier, David Ramos-Barbon, Damon Jack, Simon Piggott, Roger Owen

Respir Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
Ronald Dahl, Kian Fan Chung, Roland Buhl, Helgo Magnussen, Vladimir Nonikov, Damon Jack

Thorax· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study.
Gregory Feldman, Thomas Siler, Niyati Prasad, Damon Jack, Simon Piggott

BMC Pulm Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
Stephen Rennard, Theo Bantje, Stefano Centanni, Pascal Chanez, Alexander Chuchalin, Damon Jack

Respir Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
Jutta Beier, Pascal Chanez, Jean-Benoit Martinot, A J M Schreurs, Ruzena Tkácová, Damon Jack

Pulm Pharmacol Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis